Skip to main content
Clinical Trials/NCT01151982
NCT01151982
Completed
Not Applicable

Primary Prevention of Major Depression Based on the Level and Profile of Risk of Primary Care Attenders: Cluster, Controlled, Randomised Trial

The Mediterranean Institute for the Advance of Biotechnology and Health Research1 site in 1 country3,326 target enrollmentOctober 2010
ConditionsDepression

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression
Sponsor
The Mediterranean Institute for the Advance of Biotechnology and Health Research
Enrollment
3326
Locations
1
Primary Endpoint
Accumulated incidence of major depression
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The main objective is to measure the effectiveness of a new intervention for primary prevention of major depression based on the level and profile of risk of primary care attendees. Among the secondary objectives is to evaluate the cost-effectiveness and cost-utility of the intervention versus usual care. METHODS: This is a cluster, randomised controlled trial of a community intervention with cluster at the level of practice. It will be undertaken in primary medical care in 7 Spanish cities and 5 autonomous communities.The aim is to evaluate a new intervention for primary prevention of major depression based on patients' level and profile of risk. Family doctors in the intervention practices will provide the intervention for patients at risk. Patients at risk who are recruited in control practices will receive usual primary care. The main outcome is the accumulated incidence of major depression (measured by CIDI) during the follow-up. The investigators will assess main outcomes and other covariables at baseline, 6, 12, and 18 months. A random sample of 3,381 primary care attendees (1,690 for each arm), aged 18-75 and without major depression will be recruited in 70 health centres (140 family doctors) in 7 cities. The investigators shall undertake a logistic regression multilevel model with 4 levels (time, patient, doctor and health centre). The investigators shall also undertake multivariate gamma and quantile regression to assess respectively the cost-effectiveness and cost-utility of the new intervention versus usual care, estimating their standard errors by bootstrap.

Registry
clinicaltrials.gov
Start Date
October 2010
End Date
January 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
The Mediterranean Institute for the Advance of Biotechnology and Health Research
Responsible Party
Principal Investigator
Principal Investigator

Juan Ángel Bellón Saameño

PhD Medicine

The Mediterranean Institute for the Advance of Biotechnology and Health Research

Eligibility Criteria

Inclusion Criteria

  • Patients among those attending to primary care centers.

Exclusion Criteria

  • Age under 18 or over 75 years.
  • Unable to understand or speak Spanish.
  • Represented patients (that is, someone else comes to visit on behalf of the patient).
  • Cognitive impairment.
  • Psychosis.
  • Terminal illness.
  • Planning to be outside of the the city during 4 or more months during the next 18 months.

Outcomes

Primary Outcomes

Accumulated incidence of major depression

Time Frame: 18 months

Secondary Outcomes

  • Cost-effectiveness and cost-utility(18 months)

Study Sites (1)

Loading locations...

Similar Trials